Previous close | 29.20 |
Open | 20.63 |
Bid | 18.45 |
Ask | 24.80 |
Strike | 119.00 |
Expiry date | 2024-06-14 |
Day's range | 20.31 - 20.63 |
Contract range | N/A |
Volume | |
Open interest | 49 |
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...
Moderna stock is trading sideways despite a bevy of news, including FDA approval for its RSV vaccine. Is MRNA stock a buy right now?